Surteco Group SE (ETR:SUR)

Theseus Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49.68	71.19	111.81	117.75	73.06	133.47
Cash & Short-Term Investments	49.68	71.19	111.81	117.75	73.06	133.47
Cash Growth	-55.56%	-36.33%	-5.04%	61.18%	-45.26%	59.69%
Accounts Receivable	89.5	75.24	73.17	61.76	74.52	56.36
Other Receivables	1.35	14.21	11.17	10.01	7.88	5.75
Receivables	90.85	89.45	84.33	71.76	82.4	64.16
Inventory	154.48	148.04	139.69	142.13	140.9	109.27
Prepaid Expenses	-	6.05	3.95	4.03	3.44	2.29
Other Current Assets	18.48	4.32	3.02	6.14	3.72	1.37
Total Current Assets	313.48	319.05	342.81	341.82	303.51	310.55
Property, Plant & Equipment	315.15	309.87	314.73	256.07	254.76	243.93
Long-Term Investments	1.34	2.2	0.4	0.01	0.01	0.01
Goodwill	219.26	227.23	223.44	161.98	162.91	162.9
Other Intangible Assets	84.62	94.67	104.24	37.75	40.04	43.63
Long-Term Accounts Receivable	-	0.28	0.17	0.53	1.07	-
Long-Term Deferred Tax Assets	22.54	23.81	16.8	14.2	6.59	4.41
Long-Term Deferred Charges	-	2.09	3.14	3.86	4.33	4.27
Other Long-Term Assets	5.96	33.2	36.06	35.65	21.94	29.08
Total Assets	962.35	1,012	1,042	851.86	795.15	798.78
Accounts Payable	93.05	92.19	83.32	60.95	63.58	63.42
Accrued Expenses	-	25.19	29.72	22.72	24.42	21.23
Short-Term Debt	22.78	-	-	3.6	88.55	39.1
Current Portion of Long-Term Debt	-	9.7	62.23	-	-	-
Current Portion of Leases	-	7.04	6.45	5.91	4.23	6.17
Current Income Taxes Payable	2.79	1.8	2.39	9.26	10.69	2.6
Current Unearned Revenue	-	0.67	0.45	0.78	0.85	0.57
Other Current Liabilities	41.63	18.03	15.31	11.48	11.82	13.59
Total Current Liabilities	160.25	154.63	199.87	114.69	204.14	146.67
Long-Term Debt	381.14	370.43	378.52	237.36	115.96	219.33
Long-Term Leases	-	25.3	23.91	23.64	16.87	18.26
Long-Term Deferred Tax Liabilities	37.79	39.65	34.95	40.3	31.96	27.35
Other Long-Term Liabilities	1.61	0.21	0.19	0.25	0.65	0.6
Total Liabilities	592.3	601.92	648.89	425.79	381.47	425.45
Common Stock	15.51	15.51	15.51	15.51	15.51	15.51
Retained Earnings	231.79	287.97	279.59	302.73	293.01	257.61
Comprehensive Income & Other	122.76	107.01	97.53	107.84	105.17	100.22
Total Common Equity	370.05	410.48	392.63	426.07	413.68	373.33
Minority Interest	-	-	0.27	-	-	-
Shareholders' Equity	370.05	410.48	392.9	426.07	413.68	373.33
Total Liabilities & Equity	962.35	1,012	1,042	851.86	795.15	798.78
Total Debt	403.92	412.47	471.11	270.51	225.61	282.85
Net Cash (Debt)	-354.24	-341.28	-359.3	-152.76	-152.56	-149.39
Net Cash Per Share	-22.85	-22.01	-23.17	-9.85	-9.84	-9.63
Filing Date Shares Outstanding	15.51	15.51	15.51	15.51	15.51	15.51
Total Common Shares Outstanding	15.51	15.51	15.51	15.51	15.51	15.51
Working Capital	153.23	164.41	142.94	227.12	99.37	163.88
Book Value Per Share	23.87	26.47	25.32	27.48	26.68	24.08
Tangible Book Value	66.17	88.58	64.95	226.35	210.73	166.79
Tangible Book Value Per Share	4.27	5.71	4.19	14.60	13.59	10.76
Land	-	187.79	185.24	162.06	169.8	142.5
Machinery	-	632.82	612.92	552.85	535.41	521.02

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.